BackJournal Details
U
UROLOGIE
IF0.4
Papers160
Citations
Journal Papers 160
Publication Date
First-Line Maintenance Therapy for High-Risk Non-Muscle-Invasive Bladder Cancer (HR NMIBC) An Open-Label, Randomized Phase 2 Study of V940 in Combination with BCG Versus BCG Monotherapy in Participants with High-Risk Non-Muscle-Invasive Bladder Cancer (HR NMIBC) (INTerpath-011) - AUO Study AB 97/25
UROLOGIE
IF0.4

